Skip to main content
. 2021 Apr 17;100(6):1553–1567. doi: 10.1007/s00277-021-04514-y

Fig. 2.

Fig. 2

Overall survival (a), progression-free survival (b), and relapse incidence and non-relapse mortality (c) according to the therapy group